Koichiro Nakata

2.6k total citations · 1 hit paper
57 papers, 1.6k citations indexed

About

Koichiro Nakata is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Physiology. According to data from OpenAlex, Koichiro Nakata has authored 57 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pulmonary and Respiratory Medicine, 17 papers in Epidemiology and 11 papers in Physiology. Recurrent topics in Koichiro Nakata's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (22 papers), Medical Imaging and Pathology Studies (8 papers) and Pneumonia and Respiratory Infections (6 papers). Koichiro Nakata is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (22 papers), Medical Imaging and Pathology Studies (8 papers) and Pneumonia and Respiratory Infections (6 papers). Koichiro Nakata collaborates with scholars based in Japan, Sweden and South Korea. Koichiro Nakata's co-authors include Shoji Kudoh, Arata Azuma, Yoshio Taguchi, Toshihiro Nukiwa, Moritaka Suga, Sakae Homma, Atsuhiko Sato, Eiyasu Tsuboi, Motoharu Ohi and Sonoko Nagai and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Koichiro Nakata

55 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

2005 681 citations Arata Azuma, Toshihiro Nukiwa et al. American Journal of Respiratory and Critical Care Medicine profile →

Peers

Countries citing papers authored by Koichiro Nakata

Since Specialization

Citations

This map shows the geographic impact of Koichiro Nakata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koichiro Nakata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koichiro Nakata more than expected).

Fields of papers citing papers by Koichiro Nakata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koichiro Nakata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koichiro Nakata. The network helps show where Koichiro Nakata may publish in the future.

Co-authorship network of co-authors of Koichiro Nakata

This figure shows the co-authorship network connecting the top 25 collaborators of Koichiro Nakata. A scholar is included among the top collaborators of Koichiro Nakata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koichiro Nakata. Koichiro Nakata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy of pirfenidone and disease severity of idiopathic pulmonary fibrosis: Extended analysis of phase III trial in Japan 2015 ·Respiratory Investigation ·Yoshio Taguchi, Masahito Ebina, (unknown), Takashi Ogura, Arata Azuma, Hiroyuki Taniguchi, Yasuhiro Kondoh, Moritaka Suga, Hiroki Takahashi, Koichiro Nakata, Yukihiko Sugiyama, Shoji Kudoh, Toshihiro Nukiwa	25
2	Efficacy of inhaled N‐acetylcysteine monotherapy in patients with early stage idiopathic pulmonary fibrosis 2012 ·Respirology ·Sakae Homma, Arata Azuma, Hiroyuki Taniguchi, Takashi Ogura, (unknown), Yukihiko Sugiyama, Koichiro Nakata, Kunihiko Yoshimura, Masahiro Takeuchi, Shoji Kudoh	80
3	Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment 2011 ·Respiratory Research ·Arata Azuma, Yoshio Taguchi, Takashi Ogura, Masahito Ebina, Hiroyuki Taniguchi, Yasuhiro Kondoh, Moritaka Suga, Hiroki Takahashi, Koichiro Nakata, Atsuhiko Sato, Shoji Kudoh, Toshihiro Nukiwa	88
4	Efficacy of Gefitinib in a Patient with Lung Cancer Associated with Idiopathic Pulmonary Fibrosis 2006 ·Journal of Thoracic Oncology ·Kazuma Kishi, Koichiro Nakata, Kunihiko Yoshimura	4
5	Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis breakdown → 2005 ·American Journal of Respiratory and Critical Care Medicine ·Arata Azuma, Toshihiro Nukiwa, Eiyasu Tsuboi, Moritaka Suga, Shosaku Abe, Koichiro Nakata, Yoshio Taguchi, Sonoko Nagai, Harumi Itoh, Motoharu Ohi, Atsuhiko Sato, Shoji Kudoh, (unknown)	681
6	Promoter Analysis and Aberrant Expression of the MUC5B Gene in Diffuse Panbronchiolitis 2005 ·American Journal of Respiratory and Critical Care Medicine ·Koichiro Kamio, Ikumi Matsushita, Minako Hijikata, Yoichiro Kobashi, Goh Tanaka, Koh Nakata, Takafumi Ishida, Katsushi Tokunaga, Yoshio Taguchi, Sakae Homma, Koichiro Nakata, Arata Azuma, Shoji Kudoh, Naoto Keicho	51
7	Comparative study of doripenem and meropenem in respiratory infections. Phase III double-blind comparative study 2005 ·Atsushi Saitô, Akira Watanabe, Koichiro Nakata, (unknown), Nobuki Aoki, Toshiharu Matsushima, Shigeru Kohno, Masaru Nasu, Mitsuyoshi Nakashima, Keizo Yamaguchi, Jingoro Shimada	3
8	[Pulmonary cryptococcosis combined with pulmonary tuberculosis]. 2003 ·PubMed ·Kazuma Kishi, Sakae Homma, Atsuko Kurosaki, Masateru Kawabata, Eiyasu Tsuboi, (unknown), (unknown), (unknown), Noriko Motoi, (unknown), Koichiro Nakata	1
9	Vancomycin pharmacokinetics and dosing recommendations in patients undergoing hemodialysis 2003 ·Masahiro Igarashi, (unknown), Hideyuki Katori, Shigeko Hara, Koichiro Nakata, Masahiro Hayashi, Kenmei Takaichi, Yasuji Kasuya	1
10	A Clinical Study of Cryptococcal Meningitis 2003 ·Kansenshogaku zasshi ·Kazuma Kishi, Sakae Homma, (unknown), Koichiro Nakata	2
11	Small lung tumors with the size of 1cm or less in diameter: clinical, radiological, and histopathological characteristics 2003 ·Lung Cancer ·Kazuma Kishi, Sakae Homma, Atsuko Kurosaki, Noriko Motoi, Tadasu Kohno, Koichiro Nakata, Kunihiko Yoshimura	49
12	Fine Localization of a Major Disease-Susceptibility Locus for Diffuse Panbronchiolitis 2000 ·The American Journal of Human Genetics ·Naoto Keicho, Jun Ohashi, Gen Tamiya, Koichiro Nakata, Yoshio Taguchi, Arata Azuma, Nobuya Ohishi, Mitsuru Emi, Myoung Hee Park, Hidetoshi Inoko, Katsushi Tokunaga, Shoji Kudoh	48
13	Pleurodesis with a Combination of OK-432 and Adriamycin for Malignant Pleural Effusions Caused by Lung Cancer. 1999 ·Haigan ·Kazuma Kishi, Masateru Kawabata, Eiyasu Tsuboi, Koji Narui, Sakae Homma, (unknown), Koichiro Nakata	2
14	Successful Treatment of Refractory Bronchorrhea by Inhaled Indomethacin in Two Patients With Bronchioloalveolar Carcinoma 1999 ·CHEST Journal ·Sakae Homma, Masateru Kawabata, Kazuma Kishi, Eiyasu Tsuboi, Koji Narui, (unknown), Koichiro Nakata	22
15	Association of diffuse panbronchiolitis with microsatellite polymorphism of the human interleukin 8 (IL-8) gene 1999 ·Journal of Human Genetics ·M. Emi, Naoto Keicho, Katsushi Tokunaga, Harumi Katsumata, (unknown), Koichiro Nakata, Yoshio Taguchi, Nobuya Ohishi, Arata Azuma, Shoji Kudoh	16
16	Contribution of HLA Genes to Genetic Predisposition in Diffuse Panbronchiolitis 1998 ·American Journal of Respiratory and Critical Care Medicine ·Naoto Keicho, Katsushi Tokunaga, Koichiro Nakata, Yoshio Taguchi, Arata Azuma, Makoto Bannai, Mitsuru Emi, Nobuya Ohishi, Yoshio Yazaki, Shoji Kudoh	40
17	[Method of decreasing oral corticosteroids by adding a beclomethasone dipropionate inhaler for steroid-dependent asthmatic patients]. 1986 ·PubMed ·(unknown), Kunihiko Yoshimura, Yoshitaka Nakamori, (unknown), Koichiro Nakata, (unknown)	2
18	Clinical and Immunological Studies on Forphenicinol, a Low Molecular Weight Immunomodulator, in Chronic Respiratory Infections 1985 ·Kansenshogaku zasshi ·Kunihiko Yoshimura, (unknown), (unknown), Yoshitaka Nakamori, Koichiro Nakata, (unknown)	1
19	CLINICAL STUDIES OF CEFOTAXIME ON THE RESPIRATORY TRACT INFECTIONS 1980 ·(unknown), Koichiro Nakata, Shinichi Morinaga, (unknown), Hiroshi Okano, (unknown)	1
20	[A case of hypersensitivity pneumonitis (author's transl)]. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Koichiro Nakata, Takeshi Miura, (unknown), Hiomi Homma, Akira Yamanaka	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact